These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tabanelli GM; Miglioli M; Barbara L J Clin Gastroenterol; 1988 Aug; 10(4):406-9. PubMed ID: 3418088 [TBL] [Abstract][Full Text] [Related]
25. Retrograde distribution of a new 5-aminosalicylic acid enema in patients with ulcerative colitis. Almer S; Ekberg S; Ström M Gastroenterol Clin Biol; 1992; 16(6-7):564-8. PubMed ID: 1526419 [TBL] [Abstract][Full Text] [Related]
26. Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Campieri M; Corbelli C; Gionchetti P; Brignola C; Belluzzi A; Di Febo G; Zagni P; Brunetti G; Miglioli M; Barbara L Dig Dis Sci; 1992 Dec; 37(12):1890-7. PubMed ID: 1473437 [TBL] [Abstract][Full Text] [Related]
27. The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine. Kruis W; Bar-Meir S; Feher J; Mickisch O; Mlitz H; Faszczyk M; Chowers Y; Lengyele G; Kovacs A; Lakatos L; Stolte M; Vieth M; Greinwald R Clin Gastroenterol Hepatol; 2003 Jan; 1(1):36-43. PubMed ID: 15017515 [TBL] [Abstract][Full Text] [Related]
28. Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Pullan RD; Ganesh S; Mani V; Morris J; Evans BK; Williams GT; Rhodes J Gut; 1993 May; 34(5):676-9. PubMed ID: 8504970 [TBL] [Abstract][Full Text] [Related]
29. [Cryptogenetic ulcerative colitis. Our clinical experience with new therapeutic approaches]. Cigala O; Pancallo MT; Marasco A; Della Valle M Clin Ter; 1990 Jul; 134(2):101-10. PubMed ID: 1979263 [TBL] [Abstract][Full Text] [Related]
30. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis. Drug Ther Bull; 1992 Jun; 30(13):50-2. PubMed ID: 1628539 [No Abstract] [Full Text] [Related]
31. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054 [TBL] [Abstract][Full Text] [Related]
32. Review article: induction therapy for patients with active ulcerative colitis. Travis SP Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424 [TBL] [Abstract][Full Text] [Related]
33. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis. Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V; Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738 [TBL] [Abstract][Full Text] [Related]
34. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis. Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960 [TBL] [Abstract][Full Text] [Related]
36. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage]. Bresci G; Carrai M; Venturini G; Gambardella L Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855 [TBL] [Abstract][Full Text] [Related]
38. A case of diversion colitis treated with 5-aminosalicylic acid enemas. Tripodi J; Gorcey S; Burakoff R Am J Gastroenterol; 1992 May; 87(5):645-7. PubMed ID: 1595655 [TBL] [Abstract][Full Text] [Related]
39. 5-ASA enemas for refractory distal ulcerative colitis. An open trial. Kandel G; Prokipchuk EJ J Clin Gastroenterol; 1987 Oct; 9(5):536-40. PubMed ID: 3680902 [TBL] [Abstract][Full Text] [Related]